BUYER POOL ANALYSIS
Selling a Laboratory Services to Strategic / Industry buyers
Industry operators, larger competitors, and corporate buyers acquiring for synergies, geographic expansion, or capability fill. Typically pays a premium for clear strategic fit but discounts for integration cost and overlap.
Quick answers
- What multiple does this buyer pool pay?
- Median EV/EBITDA 11.42x across 29 disclosed deals (P25: 8.03x, P75: 22.53x). Median EV/Revenue 2.5x across 69 deals. Median deal value: $139.47M.
- How many disclosed transactions?
- 76 deals total (76 from 2018+), filtered to Strategic / Industry acquirers of laboratory services businesses.
- Most active buyers
- Sonic Healthcare Ltd (5) · Eurofins Scientific (4) · Frontage Laboratories, Inc. (3) · Labcorp (2) · Quest Diagnostics (2) · Bruker Corporation (2)
Recent disclosed deals
Strategic / Industry acquisitions of laboratory services businesses with named target, named acquirer, and disclosed financials.
| Year | Target | Acquirer | EV | EV/EBITDA | EV/Rev |
|---|---|---|---|---|---|
| 2026 | Complete Genomics, Inc. | Swiss Rockets AG | $50.0M | — | 0.16x |
| 2026 | GeneSeek (Neogen Animal Genomics) | Zoetis | $160.0M | — | 1.80x |
| 2025 | CHS Outreach Laboratory Assets | Laboratory Corporation of America Holdings | $194.5M | 6.3x | 2.10x |
| 2025 | Eurofins 2025 Acquisitions | Eurofins Scientific | $302.8M | 13.8x | 0.90x |
| 2025 | Havix Group Inc. | Senores Pharmaceuticals Limited | $1.4M | — | 2.51x |
| 2025 | OPKO / BioReference Health (Clinical Diagnostics Business) | Labcorp | $192.5M | — | 2.10x |
What this buyer pool prices for
Strategic buyers — operators in adjacent geographies, larger competitors, or corporate consolidators — price for synergies and capability fill. They tend to discount integration cost and overlap risk but pay above market when there's clear strategic fit (key customer relationship, license, geography, technician/professional team). Multiples are competitive with PE for fee-viable deals; below PE for sub-scale acquisitions.
Methodology note
Multiples shown are computed from disclosed M&A transactions in the ExitValue.ai database, filtered to laboratory services businesses acquired by strategic / industry buyers. EV/EBITDA outliers outside the [0.5x, 60x] band and EV/Revenue outliers outside [0.05x, 25x] are excluded from medians. Where available, post-2018 transactions are weighted; otherwise the all-time sample is used. Deal counts shown reflect deals with disclosed financials only — total transaction count for this buyer pool is typically 2-3x larger. Full methodology
What's your laboratory services worth to strategic / industry?
Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.
Engine-grounded estimate. Comparable strategic / industry deals on the full results page.